NHGRI/DIR Clinical Support Services

NHGRI临床主任办公室以各种方式管理遗传学和基因组学的临床支持服务。1.该办公室为医务人员开展罕见遗传病的临床研究提供广泛的行政支持。这包括为卫生保健专业人员颁发资格证书，支持他们的州执照，为急性护理提供者提供停车位，安排患者及其检查的时间表，安排临床测试合同，并为旅行、外部医疗测试，特别是基因测试提供报销。2.该办公室还为临床研究人员提供学术支持和基础设施，包括为研究所制定政策，协助招募病人，通过电话、传真或电子邮件处理病人、医生和国会的询问，就临床方案编写提供建议，通过IRB批准系统跟踪方案，设立数据安全和监测委员会并安排其每年两次会议，以及为整个研究所创建和维持统计咨询服务。临床主任还监督研究所的行政人员以及研究护士和护士从业人员，并安排病房覆盖范围。临床主任监督生命伦理学核心，并参加IRB会议。3.临床主任办公室通过促进新的倡议，如NIH未诊断疾病方案(与罕见疾病研究办公室和NIH临床中心合作)，推动NHGRI的临床和转化性研究。

The NHGRI Office of the Clinical Director manages Clinical Support Services for Genetics and Genomics in a variety of ways. 1. The Office provides extensive administrative support for medical personnel in their performance of clinical research into rare genetic diseases. This includes credentialing of health care professionals, support of their state licenses, provision of parking spaces for acute care providers, scheduling of patients and their tests, arranging contracts for clinical testing, and providing reimbursement for travel, outside medical testing, and especially genetic testing. 2. The Office also provides academic support and infrastructure for clinical investigators, including the setting of policies for the Institute, assisting in patient recruitment, handling patient, physician, and Congressional inquiries by phone, FAX, or e-mail, providing advice regarding clinical protocol writing, tracking protocols through the IRB approval system, establishing a Data Safety and Monitoring Board and arranging its meetings twice a year, and creating and maintaining a Statistical Consultation Service for the entire Institute. The Clinical Director also supervises the administrative personnel as well as research nurses and nurse practitioners for the Institute, and schedules ward coverage. The Clinical Director supervises the Bioethics Core and attends IRB meetings. 3. The Office of the Clinical Director advances clinical and translational research in the NHGRI by fostering new initiatives such as the NIH Undiagnosed Diseases Program (in collaboration with the Office of Rare Disease Research and the NIH Clinical Center).